Interim results for the six months ended 30 June 2019
4 September 2019
Preliminary results for the year ended 31 December 2018
14 March 2019
Analyst Presentation: Interim results for the six months ended 30 June 2018
13 September 2018
Analyst Presentation: Oxford BioMedica and Axovant licence agreement
21 June 2018
Preliminary results for the year ended 31 December 2017
15 March 2018
Analyst Presentation: Oxford BioMedica and Bioverativ Collaboration
15 February 2018
Jefferies Presentation
15 November 2017
Analyst Presentation: Interim results for the six months ended 30 June 2017
16 August 2017
Jefferies 2017 Global Healthcare Conference
21 June 2017
Annual general meeting 2017
21 May 2017
Preliminary results for the year ended 31 December 2016
16 March 2017
BIO CEO & Investor Conference
12 February 2017
